Milestone Pharmaceuticals in the spotlight (part II)
Starting MIST position and updates on JNCE/ATSX, all which have catalysts coming up
Following up on our first post on Milestone Pharma ($MIST), Boutique Biotech will be investing its capital into the company. This post will cover:
$XBI is finally seeing some life as big pharma is making billion-dollar acquisitions
Important Jounce Therapeutics ($JNCE) data is coming in early-December 2022
Astria Therapeutics ($ATSX) executing with data …